Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation

被引：2
|
作者：
Al-Ramahi, Joe S. [1 ]
Shahzad, Moazzam [1 ]
Nguyen, Andrea [1 ]
Li, Kevin [1 ]
Amin, Muhammad Kashif [1 ]
Ahmed, Nausheen [1 ]
Lutfi, Forat [1 ]
Dejarnette, Shaun [1 ]
Chaudhary, Sibgha Gull [1 ]
Bansal, Rajat [1 ]
Abdelhakim, Haitham [1 ]
Shune, Leyla [1 ]
Abdallah, Al-Ola [1 ]
Singh, Anurag K. [1 ]
Abhyankar, Sunil H. [1 ]
Mcguirk, Joseph P. [1 ]
Mushtaq, Muhammad Umair [1 ]
机构：
[1] Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Kansas City, KS 66045 USA
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷 / 01期
关键词：
D O I：
10.1038/s41409-023-02125-x
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
下载
收藏
页码：134 / 137
页数：4
相关论文
共 50 条
  • [31] CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease (vol 57, pg 1592, 2022)
    Rangarajan, Hemalatha G.
    Crowell, Sara A.
    Towerman, Alison S.
    Shenoy, Shalini S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (12) : 1855 - 1855
  • [32] Eltrombopag Improves Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Koshy, Nebu
    Master, Samip
    Leary, Cheri
    Bozeman, Amy
    Peyton-Thomas, Breanne
    Peddi, Prakash
    Devarakonda, Srinivas
    Mansour, Richard
    Mills, Glenn
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S284 - S286
  • [33] A boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation
    Larocca, Alessandra
    Piaggio, Giovanna
    Podesta, Marina
    Pitto, Anna
    Bruno, Barbara
    Di Grazia, Carmen
    Gualandi, Francesca
    Occhini, Domenico
    Raiola, Anna Maria
    Dominietto, Alida
    Bregante, Stefania
    Lamparelli, Teresa
    Tedone, Elisabetta
    Oneto, Rosi
    Frassoni, Francesco
    Van Lint, Maria Teresa
    Pogliani, Enrico
    Bacigalupo, Andrea
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (07): : 935 - 940
  • [34] Vaccines are safe and effective after T-cell depleted CD34-selected allogeneic hematopoietic stem cell transplantation (Allo HCT)
    Malard, F.
    Shah, G. L.
    Seier, K.
    Cho, C.
    Devlin, S. M.
    Maloy, M.
    Borrill, T.
    Palazzo, M.
    van den Brink, M.
    Perales, M-A
    BONE MARROW TRANSPLANTATION, 2017, 52 : S29 - S29
  • [35] Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation
    Chen, Juan
    Wang, Hongtao
    Zhou, Jiaxi
    Feng, Sizhou
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [36] The incidence, risk factors and outcomes of primary poor graft function after allogeneic hematopoietic stem cell transplantation
    Gao, Fei
    Shi, Jimin
    Luo, Yi
    Tan, Yamin
    Lai, Xiaoyu
    Yu, Jian
    Huang, He
    Zhao, Yanmin
    BONE MARROW TRANSPLANTATION, 2019, 54 : 249 - 250
  • [37] Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Zhao, Yanmin
    Gao, Fei
    Shi, Jimin
    Luo, Yi
    Tan, Yamin
    Lai, Xiaoyu
    Yu, Jian
    Huang, He
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1898 - 1907
  • [38] Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation
    Haen, Sebastian P.
    Schumm, Michael
    Faul, Christoph
    Kanz, Lothar
    Bethge, Wolfgang A.
    Vogel, Wichard
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (12) : 2241 - 2251
  • [39] Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation
    Sebastian P. Haen
    Michael Schumm
    Christoph Faul
    Lothar Kanz
    Wolfgang A. Bethge
    Wichard Vogel
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 2241 - 2251
  • [40] CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma
    Smith, Eric
    Devlin, Sean M.
    Kosuri, Satyajit
    Orlando, Evelyn
    Landau, Heather
    Lesokhin, Alex M.
    Chung, David J.
    Hassoun, Hani
    Lendvai, Nikoletta
    Landgren, Ola
    Giralt, Sergio
    Chari, Ajai
    Jagannath, Sundar
    Koehne, Guenther
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (02) : 258 - 267
12345